U.S. markets closed
  • S&P Futures

    4,465.75
    +20.00 (+0.45%)
     
  • Dow Futures

    34,840.00
    +166.00 (+0.48%)
     
  • Nasdaq Futures

    15,388.00
    +69.25 (+0.45%)
     
  • Russell 2000 Futures

    2,258.10
    +14.10 (+0.63%)
     
  • Crude Oil

    75.27
    +1.29 (+1.74%)
     
  • Gold

    1,758.80
    +7.10 (+0.41%)
     
  • Silver

    22.65
    +0.22 (+0.98%)
     
  • EUR/USD

    1.1730
    +0.0012 (+0.11%)
     
  • 10-Yr Bond

    1.4600
    +0.0500 (+3.55%)
     
  • Vix

    17.75
    -0.88 (-4.72%)
     
  • GBP/USD

    1.3675
    -0.0005 (-0.04%)
     
  • USD/JPY

    110.6620
    -0.0230 (-0.02%)
     
  • BTC-USD

    44,245.33
    +1,850.74 (+4.37%)
     
  • CMC Crypto 200

    1,105.31
    +2.25 (+0.20%)
     
  • FTSE 100

    7,051.48
    -26.87 (-0.38%)
     
  • Nikkei 225

    30,329.30
    +80.49 (+0.27%)
     

How Novavax Could Shake Up the COVID Vaccine Market

·4 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Moderna (NASDAQ: MRNA), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) and its partner BioNTech (NASDAQ: BNTX) share the U.S. COVID-19 vaccine market right now. In this Motley Fool Live video recorded on July 21, healthcare and cannabis bureau editor-analyst Olivia Zitkus and Motley Fool contributor Keith Speights discuss how Novavax (NASDAQ: NVAX) could potentially shake up the COVID vaccine market.